NYSE
QGEN
Qiagen N.V.
- Health Care
- Netherlands
- Listed 2026
- 1 day
- −0.5%
- 1 month
- +7.8%
- 1 year
- −16.5%
$41.73 · Mkt cap $8.60B · P/E 21.51
At the 6 Aug 2026 close
NYSE
Qiagen N.V.
$41.73 · Mkt cap $8.60B · P/E 21.51
At the 6 Aug 2026 close
Qiagen N.V. trades under the ticker QGEN on NYSE, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2026. Its market capitalisation is $8.60B. The last closing price was $41.73, on 6 Aug 2026. It trades at 21.51 times its last reported annual diluted earnings per share. Over the past year the share price is −16.5%, and +7.8% over the past month. Returns are price returns and exclude dividends.
This page exists because QGEN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.